Clinical Trials on Bladder and Bladder Neck Disorders (Excluding Calculi) in Netherlands

Total 156 results

Novartis Pharmaceuticals

Terminated

Safety and Efficacy of SAF312 in Patients With Neurogenic Detrusor Overactivity Due to Spinal Cord Lesions

Neurogenic Urinary Bladder | Neurogenic Bladder Disorder | Neurogenic Dysfunction of the Urinary Bladder | Neurogenic Bladder, Uninhibited | Neurogenic Bladder, Spastic

Netherlands, Germany, Switzerland
Wellspect HealthCare

Completed

The Value of Multiple Urine Flow Rate Measurements in Male Benign Prostatic Hyperplasia (BPH) Subjects

Lower Urinary Tract Symptoms | Bladder Outlet Obstruction

United States, Netherlands, Poland, United Kingdom
Spectrum Pharmaceuticals, Inc

Completed

Phase II Trial of EOquin in High-risk Superficial Bladder Cancer

Bladder Neoplasms

Netherlands
Maastricht University Medical Center

Completed

Effect of Pulse Rate Changes on Clinical Outcome

Overactive Bladder Syndrome | Chronic Urinary Retention

Netherlands
Maastricht University Medical Center

Unknown

Non-Micturation Bladder Activity in Relation to Self-Consciousness During Filling Phase and Sensation Measurement During the Filling Phase

Lower Urinary Tract Symptoms | Overactive Bladder Syndrome

Netherlands
Taris Biomedical LLC

Completed

Safety and Tolerability of TAR-200 mg in Subjects With Non-Muscle-Invasive Bladder Cancer

Urinary Bladder Cancer

Netherlands
Maastricht University Medical Center

Completed

Basic Sensations Coming From the Bladder

Healthy | Overactive Bladder Syndrome

Netherlands
Academisch Medisch Centrum - Universiteit van Amsterdam...

Completed

Confocal Laser Endomicroscopy in the Lower Urinary Tract

Urothelial Carcinoma | Bladder Neoplasm

Netherlands
Academisch Medisch Centrum - Universiteit van Amsterdam...
Bristol-Myers Squibb

Recruiting

A Study of Mitomycin-c/ Capecitabine ChemoRadiotherapy Combined With Nivolumab Monotherapy or Ipilumimab and Nivolumab, as Bladder Sparing Curative Treatment for Muscle Invasive Bladder Cancer: the CRIMI Study (CRIMI)

Urinary Bladder Cancer | Invasive Bladder Cancer

Netherlands
Maastricht University Medical Center
University Hospital, Antwerp; Zuyderland Hospital

Unknown

Experience Sampling Method in OAB Patients

Overactive Bladder | Overactive Bladder Syndrome

Netherlands
Maastricht University Medical Center
Scientific Foundation Urology Maastricht

Completed

Screening Method in Sacral Neuromodulation

Overactive Bladder | Urinary Retention

Netherlands
Radboud University Medical Center

Withdrawn

Overactive Bladder (OAB) Drink Advice Study

Overactive Bladder Syndrome

Netherlands
Maastricht University Medical Center

Unknown

The Effect of Position on Urge Sensation in Volunteers and in Patients With Overactive Bladder Syndrome

Overactive Bladder Syndrome

Netherlands
Neuspera Medical, Inc.

Completed

Acute Study to Evaluate a Novel Implantable Midfield Powered Device in Humans With Urinary Incontinence

Overactive Bladder

Netherlands
Maastricht University Medical Center

Completed

Time of Effect Onset in Treating Overactive Bladder or Non Obstructive Urinary Retention by Sacral Neuromodulation

Overactive Bladder | Non Obstructive Urinary Retention

Netherlands
Astellas Pharma Europe Ltd.

Terminated

An Exploratory Study to Investigate Bladder Contractions in the Storage Phase and Related Bladder Sensations in Healthy Females and Females With Overactive Bladder (OAB) Using High Resolution and Conventional Urodynamics

Overactive Bladder | Healthy Subjects

Netherlands
Academisch Medisch Centrum - Universiteit van Amsterdam...

Completed

Confocal Laser Endomicroscopy During TransUrethral Resection for Improving BC Diagnosis and Treatment (CLETUR)

Bladder Cancer | CLE

Netherlands
Ambu A/S
QserveCRO

Completed

Evaluation of Performance and Safety of Ambu® aScope™ 4 Cysto and aView™ Urologia for Flexible Cystoscopy

Lower Urinary Tract Symptoms | Bladder Disease | Cystoscope

Netherlands, Denmark
Radboud University Medical Center

Completed

Urgent-SQ in Treatment of Overactive Bladder Syndrome: 9-yr Follow up

Overactive Bladder | Urinary Incontinence, Urge | Urinary Frequency or Urgency Adverse Event

Netherlands
Academisch Medisch Centrum - Universiteit van Amsterdam...
Radboud University Medical Center

Recruiting

Phase II Study of Oral Metformin for Intravesical Treatment of Non-muscle-invasive Bladder Cancer (TROJAN)

Bladder Cancer | Superficial Bladder Cancer

Netherlands
European Organisation for Research and Treatment...

Terminated

Radiation Therapy and Chemotherapy Following Surgery in Treating Patients With Stage II or Stage III Bladder Cancer

Bladder Cancer

France, Netherlands
Rijnstate Hospital

Completed

Effect of Preload on Bladder Retention Volume During Spinal Anesthesia

Hypotension | Diuresis | Bladder Retention Volume

Netherlands
Erasmus Medical Center
Merck Sharp & Dohme LLC

Active, not recruiting

Biomarkers in Urothelial Cancer Patients Treated With Pembrolizumab (RESPONDER)

Biomarkers | Transitional Cell Carcinoma of the Bladder

Netherlands
Medical Enterprises Europe B.V.

Terminated

Hyperthermia Treatment in Conjunction With Mitomycin C Versus Bacillus Calmette-Guérin Immunotherapy (BCG) for Superficial Bladder Cancer

Neoplasms | Urologic Neoplasms | Neoplasms by Site | Urologic Diseases | Urinary Bladder Diseases | Urinary Bladder Neoplasms | Urinary Bladder Cancer | Malignant Tumor of Urinary Bladder

Austria, Israel, Italy, Netherlands
Maastricht University Medical Center

Unknown

Brain Areas Involved in Bladder Filling and Contraction

Urinary Bladder, Overactive

Netherlands
BlueWind Medical

Completed

BlueWind Medical System for the Treatment of Patients With OAB (OAB)

Over Active Bladder

Netherlands, United Kingdom
MedtronicNeuro

Terminated

Efficacy Study of Pudendal Neuromodulation for the Treatment of Neurogenic Overactive Bladder (ACCEPTANCE)

Urinary Incontinence | Detrusor Overactivity | Neurogenic Overactive Bladder

Belgium, France, United Kingdom, Germany, Italy, Netherlands
Avera Pharmaceuticals

Terminated

Safety and Efficacy of AV608 in Subjects With Idiopathic Detrusor Overactivity

Overactive Bladder Syndrome

Netherlands, United Kingdom
Axonics Modulation Technologies, Inc.

Completed

Treatment of REfractory Overactive BLadder With the AXonics Sacral Neuromodulation System (RELAX-OAB) (RELAX-OAB)

Overactive Bladder

Netherlands, France, Belgium, United Kingdom
Sanofi

Completed

SSR240600C Treatment in Women With Overactive Bladder (BILADY)

Overactive Bladder

France, Germany, Netherlands, Portugal, Czech Republic, United States, Canada
The Netherlands Cancer Institute
Karolinska Institutet; Radboud University Medical Center; University Medical... and other collaborators

Recruiting

EffectiveNess of a Multimodal preHAbilitation Program in patieNts With Bladder canCEr Undergoing Cystectomy (ENHANCE)

Bladder Carcinoma

Netherlands
The Netherlands Cancer Institute
Bristol-Myers Squibb

Active, not recruiting

Checkpoint Inhibition and Chemoradiotherapy as Bladder Sparing Treatment in UC (Indi-Blade)

Bladder Cancer | Urothelial Carcinoma

Netherlands
Cepheid
Axonal-Biostatem; Stève Consultants

Completed

A Multi-National Study In Bladder Cancer Patients to Detect Recurrences After TURB (Trans-urethral Resection of the Bladder) Earlier With the Xpert Bladder Cancer Monitor Assay (ANTICIPATE X) (ANTICIPATE X)

Non-muscle-invasive Bladder Cancer

United Kingdom, Netherlands, Spain, Sweden, Austria, Germany, Czechia, France, Italy
Allergan

Completed

Safety and Efficacy Study of AGN-214868 in Patients With Idiopathic Overactive Bladder and Urinary Incontinence

Urinary Bladder, Overactive

France, United States, Netherlands
Maastricht University Medical Center

Unknown

Ambulatory Urodynamic Evaluation of Sacral Neuromodulation for Non-Obstructive Urinary Retention

Acontractile Bladder

Netherlands
The Netherlands Cancer Institute
Bristol-Myers Squibb

Recruiting

Stage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without Relatlimab (TURANDORELA)

Neoplasms | Urologic Neoplasms | Urogenital Neoplasms | Neoplasms by Site | Urinary Bladder Diseases | Male Urogenital Diseases | Female Urogenital Diseases | Urinary Bladder Neoplasm | Female Urogenital Diseases and Pregnancy Complications | Antineoplastics Toxicity | Urogenital Diseases

Netherlands
Taris Biomedical LLC

Completed

Safety and Tolerability of GemRIS 225 mg in Subjects With Muscle-Invasive Bladder Cancer

Urinary Bladder Cancer

United States, Netherlands
Astellas Pharma Inc

Completed

Single Dose Study to Measure Blood Levels and Safety of a Drug for Children With Overactive Bladder

Overactive Bladder | Neurogenic Detrusor Overactivity

Belgium, Canada, Denmark, Netherlands, Poland, Turkey, United Kingdom
European Organisation for Research and Treatment...

Terminated

Chemotherapy With or Without Surgery in Treating Patients With Bladder Cancer

Bladder Cancer

Netherlands, Belgium, Italy, Turkey, Slovakia
Allergan

Terminated

OnabotulinumtoxinA for the Treatment of Urinary Incontinence Due to Overactive Bladder in Pediatric Patients (12 to 17)

Urinary Incontinence | Urinary Bladder | Overactive

United States, Australia, Belgium, Canada, Czechia, France, Germany, Italy, Netherlands, Norway, Poland, South Africa, United Kingdom
Radboud University Medical Center
Astellas Pharma Inc; Continentie Stichting Nederland (Continence Foundation...

Unknown

Study of Overactive Bladder in Women With Prolapse (SOAP)

Urinary Bladder, Overactive | Pelvic Organ Prolapse

Netherlands
Radboud University Medical Center

Recruiting

Multi-parametric MRI in Patients Suspected for Muscle Invasive Bladder Cancer: a New Local Staging Paradigm (BladParadigm)

Bladder Cancer

Netherlands
Erasmus Medical Center

Recruiting

Safely Reduce Cystoscopic Evaluations for Hematuria Patients (SeARCH)

Bladder Cancer | Urothelial Carcinoma | Hematuria | Urothelial Neoplasm

Netherlands
Astellas Pharma Europe B.V.

Completed

A Multinational Study Comparing the Long-term Efficacy and Safety of Two Medicines, Solifenacin Succinate and Mirabegron Taken Together, or Separately, in Subjects With Symptoms of Overactive Bladder (SYNERGY II)

Overactive Bladder | Urgency Incontinence | Urinary Bladder Overactive | Urinary Bladder Diseases\Urologic Diseases

Belgium, Russian Federation, Korea, Republic of, United States, Germany, Spain, Australia, Bulgaria, Canada, Czechia, Denmark, Estonia, Finland, Hungary, Italy, Latvia, Lithuania, Malaysia, Mexico, Netherlands, New Zealand, Norway, ... and more
Allergan

Completed

Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder

Overactive Bladder

Portugal, South Africa, Netherlands, Canada, Singapore, Brazil, United States, Taiwan, Italy, United Kingdom, France, Spain
Astellas Pharma Europe B.V.

Completed

This Was a Multinational Study Comparing the Efficacy and Safety of Two Medicines , Solifenacin Succinate and Mirabegron Taken Together, or Separately, or a Mock Treatment (Placebo) in Subjects With Symptoms of Overactive Bladder (SYNERGY)

Overactive Bladder | Urgency Incontinence | Urinary Bladder Overactive | Urinary Bladder Diseases\Urologic Diseases

United States, Argentina, Australia, Belgium, Bulgaria, Canada, China, Colombia, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Hong Kong, Hungary, Italy, Korea, Republic of, Latvia, Lithuania, Malaysia, Mexico, Netherlands and more
Queen Mary University of London
Hoffmann-La Roche

Unknown

Preoperative MPDL3280A in Transitional Cell Carcinoma of the Bladder (ABACUS)

Bladder Cancer

United Kingdom, France, Spain, Netherlands
European Organisation for Research and Treatment...

Completed

BCG With or Without Mitomycin in Treating Patients With Bladder Cancer

Bladder Cancer

Netherlands, Belgium, United Kingdom, Italy, Portugal, Turkey
Astellas Pharma Europe Ltd.

Completed

A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin) (BESIDE)

Urologic Diseases | Urinary Bladder Diseases | Urinary Bladder Overactive

United States, Armenia, Australia, Austria, Belgium, Canada, Czechia, Denmark, Finland, France, Georgia, Germany, Greece, Hungary, Ireland, Israel, Italy, Lebanon, Netherlands, Norway, Poland, Portugal, Romania, Russian Federation, Slov... and more
Bayer

Completed

A Trial to Learn How a New Liquid Form of BAY1817080 is Tolerated and Taken up by the Body of Healthy Male Participants (Part A). By Labeling BAY1817080 With a Radioactive Substance (Carbon 14) Researchers Want to Learn How the Study Drug is Processed and Excreted by the Body After Dosing (Part B)

Overactive Bladder | Diabetic Neuropathic Pain | Endometriosis Related Pain | Refractory or Unexplained Chronic Cough

Netherlands

Clinical Trials on Bladder and Bladder Neck Disorders (Excluding Calculi) in Netherlands

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Belgium

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations